Loading peptide profile…
Loading peptide profile…
Metabolic Category
THE GH RELEASER
Growth Hormone Releasing Peptide-2
GHRP-2 is a synthetic peptide that activates the ghrelin receptor. Small human studies examined growth hormone release and appetite, while clinical testing studies assessed pituitary function. It is not FDA approved.
Bodybuilders seeking GH boost · Those wanting muscle growth and recovery · Hard gainers needing appetite stimulation · Athletes recovering from injury
100-300 mcg 2-3 times daily
8-12 weeks on, 4 weeks off
Clinical team guidance, not medical advice.
Based on what vendors sell, not a recommendation.
Injection
Sold as vials by 37 vendors
By mouth
Not sold by vendors we track
Nasal spray
Not sold by vendors we track
Not FDA approved, research use onlyHow we review these guides14 research sources
GHRP-2 activates the ghrelin receptor and raised growth hormone in a small study of healthy men.
Seven healthy men consumed about 36% more food during GHRP-2 exposure than during the comparison condition.
A study in 65 older patients with pituitary tumors linked the growth hormone response to measures of adrenal function.
GHRP-2 belongs to a family of small synthetic growth-hormone-releasing peptides. In a 1993 account, Cyril Bowers discussed GHRP-2 alongside GHRP-1 and GHRP-6 as members of this research series. The family was investigated separately from growth-hormone-releasing hormone, so the similar names describe different peptide research lineages.
[Cyril Bowers on GHRP structure and kinetics, 1993](https://pubmed.ncbi.nlm.nih.gov/8374685/)
No. This profile records GHRP-2 as not FDA approved and for research use only. Review the regulatory and source details on this page for the current context.
Dose: 100-300 mcg 2-3 times daily. Schedule: eod. Cycle: 8-12 weeks on, 4 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 14 curated or current research sources. Inspect the research section and the citations beneath the research answers for their supporting sources.
Review the GHRP-2 research sourcesReported side effects of GHRP-2 include Increased appetite. They are reported or occasional reactions, not a prediction of what any one person will experience.
GHRP-2 has an editorial safety grade of B (Good Safety). Small human experiments and diagnostic studies provide limited safety data. The FDA notes possible immune reactions and serious event reports with uncertain causation. Safety depends on dose, sourcing, health history and medical supervision, so this page does not call it safe for personal use.
In an observational study of 104 patients, 45 (43%) were found to have severe growth hormone deficiency when diagnosed using GHRP-2 tests. The 104 patients included 85 with non-functioning pituitary adenomas (NFPA) and 19 with Rathke's cysts. In a separate retrospective study of adolescents, median growth hormone peaks after GHRP2 were 3.4 ng/mL in the organic or genetic GHD group, 88.9 ng/mL in the idiopathic GHD group, and 90.1 ng/mL in the short stature group.
In-stock prices from 37 vendors, checked Nov 10, 2026.
Market evidence
We found certificates from some of the GHRP-2 vendors we track. Based on the certificates our crawler found; vendors may publish more than we index. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.
The clinic network
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves
A growth hormone releasing peptide with limited human research
from $1.92/mg · 92 vendorsNº 003 / 006FDA-approved dual GIP and GLP-1 agonist for diabetes and obesity
from $0.98/mg · 564 vendorsNº 006 / 006Myostatin-trapping fusion protein; development halted over bleeding
from $36.20/mg · 19 vendorsNº 001 / 006A natural protein that restrains skeletal muscle growth
from $105 · 8 vendorsNº 002 / 006A modified IGF-1 analogue used in laboratory research
from $4.95/mg · 153 vendorsNº 004 / 006Ghrelin-mimicking small molecule, investigational and not FDA-approved
Full profileNº 005 / 006